Zacks Investment Research on MSN12d
Stereotaxis Stock Slides Despite MAGiC Sweep Catheter FDA SubmissionStereotaxis STXS recently submitted an application seeking FDA regulatory clearance for its MAGiC Sweep catheter, which is ...
In addition to the FDA 510 (k) submission, Stereotaxis expects to submit both catheters for CE mark clearance in Europe this ...
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced FDA regulatory submission for the MAGiC Sweep™ catheter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results